Læknablaðið - 15.11.1991, Blaðsíða 22

346
LÆKNABLAÐIÐ
HEIMILDIR
1. Prince AM, Brotman B, Gardy GF, et al. Long-
incubation post-transfusion hepatitis without
serological evidence of exposure to hepatitis-B virus.
Lancet 1974; 2: 241-6.
2. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ,
Holland PV. Transfusion-associated hepatitis not due
to viral hepatitis type A or B. N Engl J Med 1975;
292: 767-70.
3. Dienstag JL, Alaama A, Mosley JW, Redeker AG,
Purcell RH. Etiology of sporadic hepatitis B surface
antigen-negative hepatitis. Ann Intem Med 1977; 87:
1-6.
4. Alter HJ, Purcell RH, Holland PV, Popper H.
Transmissible agent in non-A, non-B hepatitis.
Lancet 1978; 1: 459-63.
5. Tabor E, Gerety RJ, Dmcker JA, et al. Transmission
of non-A, non-B hepatitis from man to chimpanzee.
Lancet 1978; 1: 463-6.
6. Khuroo MS. Study of an epidemic of non-A, non-B
hepatitis. Possibility of another human hepatitis vims
distinct from post-transfusion non-A, non-B type. Am
J Med 1980; 68: 818-23.
7. Krawczynski K. Vims-associated antigen and specific
antibodies of epidemic non-A, non-B hepatitis (HEV)
in outbreaks and sporadic cases of NANB hepatitis.
Liver Update 1989; 3: 5-6.
8. Zuckerman AJ. Hepatitis E virus. The main cause
of enterically transmitted non-A, non-B hepatitis. Br
Med J 1990; 300; 1475.
9. Reyes GR, Purdy MA, Kim JP, et al. Isolation of
a cDNA from the vims responsible for enterically
transmitted non-A, non-B hepatitis. Science 1990;
247: 1335-9.
10. Knodell RG, Conrad ME, Ishak KG. Development
of chronic liver disease after non-A, non-B
post-transfusion hepatitis: role of globulin in its
prevention. Gastroenterology 1977; 72: 902-9.
11. Berman M, Alter HJ, Ishak KG, Purcell RH, Jones
EA. The chronic sequelae of non-A, non-B viral
hepatitis. Ann Int Med 1979; 91: 1-6.
12. Realdi G, Alberti A, Rugge M, et al. Long-term
follow-up of acute and chronic non-A, non-B post-
transfusion hepatitis: evidence of progression to Iiver
cirrhosis. Gut 1982; 23: 270-5.
13. Dienstag JL. Non-A, non-B hepatitis. 1. Recognition,
epidemiology, and clincal features. II. Experimental
transmission, putative vims agents and markers, and
prevention. Gastroenterology 1983; 85: 439-62, 743-
68.
14. Omata M, Iwama S, Sumida M, Ito Y, Okuda K.
Clinicopathological study of acute non-A, non-B post
transfusion hepatitis: histological features of liver
biopsies in acute phase. Liver 1981; 1: 201-8.
15. Dienes HP, Popper H, Lobeck H. Histologic
observations in human hepatitis non-A, non-B.
Hepatology 1982; 2: 562-71.
16. Kryger P, Christopherson P. Light microscopic
morphology of acute hepatitis non-A, non-B: a
comparison with hepatitis type A and B. Liver 1982;
2: 200-6.
17. Schmid M, Pirovino M, Altorfer J, Gudat F, Bianchi
L. Acute hepatitis non-A, non-B: are there any
specific light microscopic features? Liver 1982; 2:
61-7.
18. Lefkowitch JH, Apfelbaum TF. Non-A, non-B
hepatitis: characterization of Iiver biopsy pathology. J
Clin Gastroenterol 1989; 11: 225-32.
19. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley
DW, Houghton M. Isolation of a cDNA clone
derived from a blood-bome non-A, non-B viral
hepatitis genome. Science 1989; 244: 359-62.
20. Kuo G, Choo QL, Alter HJ, et al. An assay for
circulating antibodies to a major etiologic vims of
human non-A, non-B hepatitis. Science 1989; 244:
361-4.
21. Roggendorf M, Deinhardt F, Rasshofer R, et al.
Antibodies to hepatitis C vims. Lancet 1989; 2: 324-
5.
22. van der Poel CL, Reesink HW, Lelie PN, et al.
Anti-hepatitis C antibodies and non-A, non-B post-
transfusion hepatitis in the Netherlands. Lancet 1989;
2: 297-8.
23. Alter HJ, Purcell RH, Shih JW, et al. Detection
of antibody to hepatitis C vims in prospectively
followed transfusion recipients with acute and
chronic non-A, non-B hepatitis. N Engl J Med 1989;
321: 1494-1500.
24. Colombo M, Kuo G, Choo QL, et al. Prevalence of
antibodies to hepatitis C vims in Italian patients with
hepatocellular carcinoma. Lancet 1989; 2: 1006-8.
25. Sansonno D, Dammacco F. Antibodies to hepatitis C
vims in nonA, nonB post-transfusion and cryptogenic
chronic liver disease. Lancet 1989; 2: 798-9.
26. Stevens CE, Taylor PE, Pindyck J, et al.
Epidemiology of hepatitis C virus. A preliminary
study in volunteer blood donors. JAMA 1990;
263(1); 49-53.
27. Janot C, Courouce AM, Mainez M. Antibodies to
hepatitis C vims in French blood donors. Lancet
1989; 2: 796-7.
28. Sirchia G, Bellobuono A, Giovanetti A, Marconi
M. Antibodies to hepatitis C virus in Italian Blood
donors. Lancet 1989; 2: 797.
29. Watanabe J, Minegishi K, Mitsumori T, et al.
Prevalence of anti HCV antibody in blood donors
in the Tokyo area. Vox Sang 1990; 59(2): 86-8.
30. Kiihnl P, Seidl S, Stangel W, Beyer J, Sibrowski W,
Flik J. Antibody to hepatitis C virus in German blood
donors. Lancet 1989; 2: 324.
31. Williams E, Dodd Y. The serology of hepatitis C
vims in relation to post-tranfusion hepatitis. Ann Clin
Lab Sci 1990; 20(3): 192-9.
32. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis
C vims antibodies among risk groups in Spain.
Lancet 1989; 2: 294-7.
33. Noel L, Guerois C, Maisonneuve P, Verroust
F, Laurian Y. Antibodies to hepatitis C vims in
haemophilia. Lancet 1989; 2: 560-1.
34. Ludlam CA, Chapman D, Cohen B, Litton PA.
Antibodies to hepatitis C vims in haemophilia.
Lancet 1989; 2: 560-1.
35. Mortimer PP, Cohen BJ, Litton PA, et al. Hepatitis C
vims antibody. Lancet 1989; 2: 798.
36. Bmix J, Barbera JM, Calvet X, et al. Prevalence of
antibodies to hepatitis C virus in Spanish patients
with hepatocellular carcinoma and hepatic cirrhosis.
Lancet 1989; 2: 1004-6.
37. Colombo M, Kuo G, Choo QL, et al. Prevalence of
antibodies to hepatitis C vims in Italian patients with
hepatocellular carcinoma. Lancet 1989; 2: 1006-8.
38. Lenzi M, Ballardini G, Fusconi M, et al. Type 2
autoimmune hepatitis and hepatitis C vims infection.
Lancet 1990; 335: 258-9.
39. McFarlane IG, Smith HM, Johnson PJ, Bray GP,
Vergani D, Williams R. Hepatitis C vims antibodies
in chronic active hepatitis: pathogenetic factor or
false-positive result. Lancet 1990; 335: 754-7.